- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2016
- Public Summary Document (PSD) November 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2016 PBAC Meeting - Word
Fosaprepitant – November 2016
Fosaprepitant: Powder for I.V. infusion 150 mg; Emend® IV
Last updated
3 March 2017